Erythroleukemia following melphalan therapy for multiple myeloma.
D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced*; D008297:Male; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*
D008558:Melphalan